Iconplc.com - SEO Checker

¡Registrarme gratis! Exportar PDF
Visión general del análisis SEO
Metadatos
61% 
Calidad de la página
90% 
Estructura
29% 
Enlazado
60% 
Servidor
100% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
0,23 s
Tamaño HTML
139,00 kB
Palabras
885
Medios
40
Cantidad de enlaces
130 internos / 19 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
ICON plc | Clinical Research Organisation (CRO) for Drug Development
Con 644 píxeles, el título de esta página es demasiado largo. Optimizar el título
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
La meta descripción es demasiado larga: 1000 píxelesOptimizar la descripción.
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
https://www.iconplc.com/
La página tiene una redirección canónica correcta.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en
Ubicación geográfica del servidor: Estados Unidos de América
El idioma ha sido correctamente declarado en el código HTML: en.
Enlaces Alternate/Hreflang
(Poco importante)
No se ha encontrado ningún enlace alternativo (alternate) en esta página.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
descriptionICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
keywordsicon clinical research, icon, icon plc, clinical research orgnisation, CRO, outsourced pharmaceutical services, healthcare intelligence, ICLR, clinical trials, clinical research, cro's, cro, cro services
GeneratorDrupal 10 (https://www.drupal.org)
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1.0
langen
charsetutf-8

¡Analiza ya gratis hasta 1.000 páginas de iconplc.com!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Calidad de la página

Contenido
(Extremadamente importante)
El número total de palabras en la página es bueno: 885 palabras.
Un 20.5% del contenido está constituido por palabras vacías.
Las palabras clave del título también se repiten en el texto del cuerpo.
Las palabras del encabezado H1 también aparecen en el cuerpo del texto.
La página contiene un listado, lo que indica una buena estructuración del contenido.
Se han encontrado 10 párrafos en esta página.
El contenido en formato texto de esta página es óptimo.
No se detecta ningún placeholder de texto ni imagen.
No se detecta contenido duplicado.
La cantidad media de palabras por frase es buena: 16.36 palabras.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
No se ha especificado ningún icono de Apple Touch.
El valor de la etiqueta viewport es correcto: (width=device-width, initial-scale=1.0).
Etiquetas Bold y Strong
(Poco importante)
El uso de etiquetas de negritas en esta página es óptimo. Te recomendamos emplear hasta 18 etiquetas de negritas en una página.
Optimización de imágenes
(Poco importante)
La descripción del atributo ALT se utiliza correctamente en todas las imágenes rastreadas.
Redes Sociales
(Deseable)
Esta página apenas ofrece posibilidades de compartir el contenido en redes sociales. Con la integración de widgets puedes conseguir que tus contenidos se popularicen en redes.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Lista de medios

URLAtributo ALTTítulo
/themes/custom/iconplc/logo.svgHomeHome
...D.jpg?crop=yes&w=260&h=136&itok=ON7iy4SbMega navigation image for ICON website MDDMega navigation image for ICON website MDD
...r.jpg?crop=yes&w=260&h=136&itok=1Ke8IvVUTechnologies-homepage banner.jpgTechnologies-homepage banner.jpg
...v.png?crop=yes&w=260&h=136&itok=2BehM837ICON Biotech website mega nav.pngICON Biotech website mega nav.png
...d.jpg?crop=yes&w=260&h=136&itok=G-zf8UeSicon-and-you-mdd.jpgicon-and-you-mdd.jpg
...D.jpg?crop=yes&w=260&h=136&itok=uC8WvnPeObesity_MDD.jpgObesity_MDD.jpg
...o.jpg?crop=yes&w=260&h=136&itok=vjc4L3FWcells-menu-hero.jpgcells-menu-hero.jpg
...D.jpg?crop=yes&w=260&h=136&itok=CxdnTOcTblended solutionsblended solutions
...r.jpg?crop=yes&w=260&h=136&itok=L2DKrduJOncology whitepaper web assetsOncology whitepaper web assets
...r.jpg?crop=yes&w=260&h=136&itok=y5yqAcQ3Oncology-youngadults_thumbnail_whitepaper.jpgOncology-youngadults_thumbnail_whitepaper.jpg
...7.jpg?crop=yes&w=260&h=136&itok=G41JOy9udosimetry thumbnaildosimetry thumbnail
...s.png?crop=yes&w=260&h=136&itok=9VAvt4U4ft-thumbnail-event-financial times.pngft-thumbnail-event-financial times.png
...d.jpg?crop=yes&w=260&h=136&itok=G2Th_4sAesg-mdd.jpgesg-mdd.jpg
...r.png?crop=yes&w=260&h=136&itok=2HCbMa0Rhealthcare-intelligence-video-poster.pnghealthcare-intelligence-video-poster.png
...D.jpg?crop=yes&w=545&h=286&itok=ORloTT_cObesity_MDDObesity_MDD
...r.jpg?crop=yes&w=545&h=286&itok=2OvldL8yOncology-youngadults_thumbnail_whitepaperOncology-youngadults_thumbnail_whitepaper
...a.jpg?crop=yes&w=545&h=286&itok=JLUN3xTZthumbnail-whitepaper-Cassandrathumbnail-whitepaper-Cassandra
...).jpg?crop=yes&w=545&h=286&itok=DQSy3IGJwhitepaper_navigating real world healthcare data integr_thumbnail_Home Page Banner 1440 x 750 (1)whitepaper_navigating real world healthcare data integr_thumbnail_Home Page Banner 1440 x 750 (1)
...r.png?crop=yes&w=545&h=286&itok=0xH3mFasblended-solutions-thumbnail-homepage bannerblended-solutions-thumbnail-homepage banner
...1.jpg?crop=yes&w=545&h=286&itok=hCz47T-BHuman First Integration_ Standard Banner_v1Human First Integration_ Standard Banner_v1
...b.jpg?crop=yes&w=545&h=286&itok=OJjSiYeGbiotech-collegesinlabbiotech-collegesinlab
...r.png?crop=yes&w=545&h=286&itok=z2ePwU5Dcardiac_safety solutions_standard_bannercardiac_safety solutions_standard_banner
...b.jpg?crop=yes&w=545&h=286&itok=XKvT9JSiearly-clinical-trials-labearly-clinical-trials-lab
...t.png?crop=yes&w=545&h=286&itok=KMnDZstzsite-and-patient-recruitmentsite-and-patient-recruitment
...0.jpg?crop=yes&w=545&h=286&itok=Wqr-usyOVideo-Conferencing-Mockup_v2_2880x1500Video-Conferencing-Mockup_v2_2880x1500
...l.jpg?crop=yes&w=545&h=286&itok=0QshaXVBspecialty labs-thumbnailspecialty labs-thumbnail
...op=yes&w=1110&h=583&a=0,48&itok=DYcsNtmEdosimetry thumbnaildosimetry thumbnail
...rop=yes&w=370&h=194&a=0,16&itok=VrabuKKKglobal strategies regulatory translationglobal strategies regulatory translation
...op=yes&w=1110&h=583&a=0,48&itok=ukOz81pZthumbnail-FDA_guidance_DMC_1110x678pxthumbnail-FDA_guidance_DMC_1110x678px
...5.png?crop=yes&w=210&h=210&itok=NdmhLEvqMeeting 15Meeting 15
...y.jpg?crop=yes&w=210&h=210&itok=KBrcF5ywAccelerated-Early-Clinical-Manufacturing-in-OncologyAccelerated-Early-Clinical-Manufacturing-in-Oncology
...e.jpg?crop=yes&w=210&h=210&itok=-DrHItKkNurse demonstrating wearableNurse demonstrating wearable
...l.jpg?crop=yes&w=210&h=210&itok=le3uWwf8enhancing-diversityenhancing-diversity
...r.jpg?crop=yes&w=210&h=210&itok=6Z-zwY7sdata transparency blog bannerdata transparency blog banner
...x.jpg?crop=yes&w=210&h=210&itok=2-vNXeH1digital health thumbnaildigital health thumbnail
...x.jpg?crop=yes&w=210&h=210&itok=1FCmqHzqcybersecurity thumbnailcybersecurity thumbnail
...l.jpg?crop=yes&w=210&h=210&itok=Cymthcrtpill_drug_reduction_thumbnailpill_drug_reduction_thumbnail
...e.jpg?crop=yes&w=210&h=210&itok=gcZWOvPOpills_drugspills_drugs
...src/assets/images/ICON_positive_logo.svgICON plcICON plc

Estructura de la página

Encabezado H1
(Extremadamente importante)
De-risking clinical development of precision medicines in oncology
Más de un encabezado H1.
Encabezados
(Importante)
Algunos de los encabezados H se repiten dos veces.
En la estructura de los encabezados H faltan uno o varios niveles.
Hay 42 encabezados H en esta página. La cantidad de encabezados debería guardar una mejor proporción en relación al texto.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H1 De-risking clinical development of precision medicines in oncology
H1 Embracing a blended operating model
H1 Advances in imaging biomarkers
H1 Demystifying EU CTR, MDR and IVDR
H1 How can we help?
H2 Featured Solutions
H2 Webinars
H2 ICON Insights
H2 What’s happening in ICON
H2 Legal Footer
H3 The benefits of going big: Why small biotechs need large CRO partners
H3 Accelerating ATMP and CGT: The importance of Regulatory CMC expertise in efficient biologics development
H3 Why using COAs and DHTs together is the future of clinical research
H3 Enhancing diversity in clinical trials
H3 Unlocking the value of transparent healthcare data
H3 Digital health: Why evaluating human factors is essential
H3 Digital health: Managing cybersecurity risks
H3 Navigating the impacts of the Inflation Reduction Act (IRA): Strategic considerations for pharma
H3 Medicare Part D Price Negotiations update – Widespread impact on the industry
H4 Clinical solutions
H4 Sectors
H4 News & Events
H4 A multifaceted risk factor: Addressing obesity's impact across the disease spectrum
H4 Strategies for commercialising oncology treatments for young adults
H4 Applying AI to manage the risks and costs of postmarketing requirements
H4 The triad of trust: Navigating real-world healthcare data integration
H4 Blended solutions
H4 Outcome Measures
H4 Biotech
H4 Cardiac Safety Solutions
H4 Early Clinical and Bioanalytical Solutions
H4 Site & Patient Solutions
H4 Market Access
H4 Specialty Laboratory Solutions
H4 Dosimetry in clinical trials
H4 Unlocking global strategies with proactive regulatory translation management
H4 Changes to the FDA guidance on Data Monitoring Committees in clinical trials
H6 Site Branding
H6 For Clients
H6 ICON for
H6 News & Events Texto duplicado
H6 Socials
Algunos textos ancla son demasiado largos.
Algunos textos ancla se repiten más de una vez en varios enlaces.
Hay 2 links con un texto ancla que no es suficientemente relevante.
La cantidad de enlaces internos es adecuada.
Ningún enlace interno contiene parámetros dinámicos.
Hay 19 enlaces externos en esta página.

Enlaces detectados en esta página

EnlacePropiedadesTexto ancla
https://www.iconplc.com/Texto ancla Skip to main content
https://www.iconplc.com/IMG-ALT Home
https://www.iconplc.com/solutionsSolutions
/solutions/blended-solutionsBlended Solutions
/solutions/cardiac-safety-solu...Cardiac Safety Solutions
/solutions/clinical-scientific...Clinical & Scientific Operations
/solutions/decentralised-clini...Decentralised Clinical Trials
/solutions/early-clinicalEarly Clinical
/solutions/laboratoriesLaboratories
/solutions/medical-imagingMedical Imaging
/solutions/site-and-patient-so...Site & Patient Solutions
/solutions/strategic-solutionsStrategic Solutions
/solutions/consulting/asset-de...Asset Development Consulting
/solutions/consulting/commerci...Commercial Positioning
/solutions/language-servicesLanguage Services
/solutions/real-world-intellig...Real World Intelligence
/solutions/consulting/regulato...Regulatory Affairs
/solutions/real-world-intellig...Symphony Health data
/solutions/outcome-measuresOutcome Measures COAs and DHTs – measure what matters
IMG-ALT Mega navigation image for ICON website MDD
/solutions/technologiesTechnologies Technology solutions from early phase through to post-marketing.
IMG-ALT Technologies-homepage banner.jpg
https://www.iconplc.com/sectorsSectors
https://www.iconplc.com/sectorsTexto ancla no relevante
Read more
/sectors/biotechBiotech
/sectors/government-and-public...Government and Public Health
/sectors/medical-deviceMedical Device
/sectors/pharmaPharmaceuticals
/sectors/biotechBiotech Developing transformative therapies requires a flexible approach.
IMG-ALT ICON Biotech website mega nav.png
/sectors/pharmaceuticals/partn...ICON and You Partners making a difference.
IMG-ALT icon-and-you-mdd.jpg
/therapeuticsTherapeutics
/therapeuticsTexto duplicado Therapeutics
/therapeutics/cardiovascularCardiovascular
/therapeutics/central-nervous-...Central Nervous System
/therapeutics/endocrine-metabo...Endocrine & Metabolic Disorders
/therapeutics/infectious-diseasesInfectious Diseases
/therapeutics/internal-medicin...Internal Medicine & Immunology
/therapeutics/oncologyOncology
/therapeutics/biosimilarsBiosimilars
/therapeutics/cell-and-gene-th...Cell and Gene Therapies
/therapeutics/medical-deviceTexto duplicado Medical Device
/therapeutics/paediatricsPaediatrics
/therapeutics/rare-orphan-dise...Rare & Orphan Diseases
/therapeutics/vaccinesVaccines
/therapeutics/womens-healthWomen's Health
/therapeutics/endocrine-metabo...Obesity A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
IMG-ALT Obesity_MDD.jpg
/insights/therapeuticsTherapeutics insights ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
IMG-ALT cells-menu-hero.jpg
https://www.iconplc.com/insightsInsights
https://www.iconplc.com/insightsTexto duplicado Insights
/insights/digital-disruptionDigital Disruption
/insights/patient-centricityPatient Centricity
/insights/regulatory-intelligenceRegulatory Intelligence
/insights/therapeuticsTherapeutics insights
/insights/transforming-trialsTransforming Trials
/insights/value-based-healthcareValue Based Healthcare
/insights/blogBlog
/insights/videosVideos
https://webinars.iconplc.com/Externo Subdominio Webinar Channel
/insights/transforming-trials/...Embracing a blended operating model Maximising efficiency and flexibility with custom outsourcing
IMG-ALT blended solutions
/insights/therapeutics-insight...De-risking clinical development of precision medicines in oncology An evolving understanding of cancer biology has resulted in the rise of precision-informed...
IMG-ALT Oncology whitepaper web assets
/insights/value-based-healthca...Strategies for commercialising oncology treatments for young adults Oncology treatments tailored specifically for young adults.
IMG-ALT Oncology-youngadults_thumbnail_whitepaper.jpg
/news-eventsNews & Events
/news-eventsTexto duplicado Texto ancla no relevante
Read more
/news-events/press-releasesPress releases
/news-events/thought-leadershipIn the News
/news-events/mediakitMediakit
/news-events/awardsAwards
/news-events/eventsEvents
/news-events/events/webinarsWebinars
/news-events/social-mediaSocial media
/news-events/events/webinars/d...Dosimetry in clinical trials 24 October 2024
IMG-ALT dosimetry thumbnail
/news-events/events/industry/f...Financial Times Global Pharma and Biotech Summit 5-7 November 2024
IMG-ALT ft-thumbnail-event-financial times.png
https://www.iconplc.com/aboutAbout ICON
https://www.iconplc.com/aboutTexto duplicado About ICON
/about/company-historyCompany history
/about/healthcare-intelligenceHealthcare Intelligence
/about/icon-in-asia-pacificICON in Asia Pacific
/about/icon-in-latin-americaICON in Latin America
/about/leadershipLeadership
/about/qualityQuality
https://www.accellacare.com/Nueva ventana Externo Subdominio Patients
https://iconstudies.com/Nueva ventana Externo Volunteers
/investigatorsInvestigators
https://careers.iconplc.com/Nueva ventana Externo Subdominio Jobs & Careers
https://investor.iconplc.com/Nueva ventana Externo Subdominio Investors
/about-icon/environmental-soci...Suppliers
/about/esg/Sustainability, diversity and charity ICON Cares is our commitment to making a positive impact on our people, environment and our community.
IMG-ALT esg-mdd.jpg
/about/clinical-research-evolved/Healthcare Intelligence Clinical Research. Evolved.
IMG-ALT healthcare-intelligence-video-poster.png
https://careers.iconplc.com/Nueva ventana Externo Subdominio Careers
http://investor.iconplc.com/Nueva ventana Externo Subdominio Texto duplicado Investors
https://www.iconplc.com/contactContact
https://iconplc.co.jp/Nueva ventana Externo 日本語
https://china.iconplc.com/Nueva ventana Externo Subdominio 简体中文
https://www.iconplc.com/Texto ancla Sin texto
/insights/therapeutics/oncolog...Read the whitepaper
/insights/transforming-trials/...Texto duplicado Read the whitepaper
/insights/therapeutics-insight...Texto duplicado Read the whitepaper
/insights/regulatory-intellige...Texto duplicado Read the whitepaper
/insights/therapeutics/endocri...A multifaceted risk factor: Addressing obesity's impact across the disease spectrum Considerations for clinical trial design focused on obesity treatments.
IMG-ALT Obesity_MDD
/insights/value-based-healthca...Strategies for commercialising oncology treatments for young adults In this whitepaper we delve into the dynamic landscape of oncology treatments tailored sp...
IMG-ALT Oncology-youngadults_thumbnail_whitepaper
/insights/digital-disruption/a...Applying AI to manage the risks and costs of postmarketing requirements Cassandra offers up to 99% accuracy predicting the need for PMRs
IMG-ALT thumbnail-whitepaper-Cassandra
/insights/digital-disruption/t...The triad of trust: Navigating real-world healthcare data integration Uncover how reshaping data and integration strategies can empower your organisation.
IMG-ALT whitepaper_navigating real world healthcare data integr_thumbnail_Home Page Banner 1440 x 750 (1)
/sectors/pharmaceuticals/blend...Blended solutions Bespoke, seamless solutions to meet unique sponsor challenges.
IMG-ALT blended-solutions-thumbnail-homepage banner
/solutions/outcome-measuresOutcome Measures A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
IMG-ALT Human First Integration_ Standard Banner_v1
/sectors/biotechBiotech ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
IMG-ALT biotech-collegesinlab
/solutions/cardiac-safety-solu...Cardiac Safety Solutions End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
IMG-ALT cardiac_safety solutions_standard_banner
/solutions/early-phaseEarly Clinical and Bioanalytical Solutions Innovative early clinical solutions that will advance your drug development strategy.
IMG-ALT early-clinical-trials-lab
/solutions/site-and-patient-so...Subdominio Site & Patient Solutions Transforming recruitment through patient-centric trials and real-world, real-time data.
IMG-ALT site-and-patient-recruitment
/solutions/consulting/commerci...Market Access Expertise in mission-critical pricing, market access, and reimbursement.
IMG-ALT Video-Conferencing-Mockup_v2_2880x1500
/solutions/laboratories/specia...Specialty Laboratory Solutions Supporting precision medicine programs across all phases of drug diagnostic co-development.
IMG-ALT specialty labs-thumbnail
/news-events/events/webinars/d...Dosimetry in clinical trials 24 October 2024. Register today.
IMG-ALT dosimetry thumbnail
/news-events/events/webinars/u...Unlocking global strategies with proactive regulatory translation management 15 November 2024. Register today.
IMG-ALT global strategies regulatory translation
/news-events/events/webinars/f...Changes to the FDA guidance on Data Monitoring Committees in clinical trials Watch the webinar
IMG-ALT thumbnail-FDA_guidance_DMC_1110x678px
/insights/blog/2024/10/21/bene...21 Oct 2024 The benefits of going big: Why small biotechs need large CRO partners Read more
IMG-ALT Meeting 15
/insights/blog/2024/08/26/acce...09 Oct 2024 Accelerating ATMP and CGT: The importance of Regulatory CMC expertise in efficient biologics development Read more
IMG-ALT Accelerated-Early-Clinical-Manufacturing-in-Oncology
/insights/blog/2024/10/08/why-...08 Oct 2024 Why using COAs and DHTs together is the future of clinical research Read more
IMG-ALT Nurse demonstrating wearable
/insights/blog/2024/10/07/enha...07 Oct 2024 Enhancing diversity in clinical trials Read more
IMG-ALT enhancing-diversity
/insights/blog/2024/10/01/unlo...01 Oct 2024 Unlocking the value of transparent healthcare data Read more
IMG-ALT data transparency blog banner
/insights/blog/2024/09/27/digi...27 Sep 2024 Digital health: Why evaluating human factors is essential Read more
IMG-ALT digital health thumbnail
/insights/blog/2024/09/26/digi...26 Sep 2024 Digital health: Managing cybersecurity risks Read more
IMG-ALT cybersecurity thumbnail
/insights/blog/2024/09/09/navi...09 Sep 2024 Navigating the impacts of the Inflation Reduction Act (IRA): Strategic considerations for pharma Read more
IMG-ALT pill_drug_reduction_thumbnail
/insights/blog/2024/09/09/medi...09 Sep 2024 Medicare Part D Price Negotiations update – Widespread impact on the industry Read more
IMG-ALT pills_drugs
/news-events/social-media/What’s happening in ICON
https://www.iconplc.com/contactTexto duplicado Contact
https://www.iconplc.com/aboutTexto duplicado About ICON
https://investor.iconplc.com/f...Nueva ventana Externo Subdominio Results & Reports
/therapeuticsTexto duplicado Therapeutics
https://www.iconplc.com/solutionsTexto duplicado Solutions
https://www.iconplc.com/insightsTexto duplicado Insights
/solutions/technologiesTechnologies
/preferencesContent preferences
/contact/global-office-locatorOffice locations
https://www.accellacare.com/Nueva ventana Externo Subdominio Texto duplicado Patients
https://iconstudies.com/Nueva ventana Externo Texto duplicado Volunteers
/investigatorsTexto duplicado Investigators
https://careers.iconplc.com/Nueva ventana Externo Subdominio Texto duplicado Jobs & Careers
https://investor.iconplc.com/Nueva ventana Externo Subdominio Texto duplicado Investors
/procurement-terms/icon-suppliersTexto duplicado Suppliers
/news-events/press-releasesTexto duplicado Press releases
/news-events/mediakitTexto duplicado Mediakit
/news-events/eventsTexto duplicado Events
/news-events/social-mediaSocial media dashboard
https://www.linkedin.com/compa...Nueva ventana Externo Subdominio Linkedin
A-TITLE Icon on Linkedin
https://twitter.com/ICONplcNueva ventana Externo A-TITLE Icon on Twitter
https://www.facebook.com/icon....Nueva ventana Externo Subdominio Facebook
A-TITLE Icon on Facebook
https://www.instagram.com/icon...Nueva ventana Externo Subdominio Instagram
A-TITLE Icon on Instagram
https://www.youtube.com/user/I...Nueva ventana Externo Subdominio Youtube
A-TITLE Icon on Youtube
https://iconplc.com/disclaimer/Disclaimer
https://www.iconplc.com/privacyPrivacy & Data
https://iconplc.com/site-cookies/Cookies
https://www.iconplc.com/Texto ancla Website

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://www.iconplc.com/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
Esta página utiliza GZip para la transmisión de datos comprimidos.
Rendimiento
(Poco importante)
El tiempo de respuesta de la página HTML es excelente: 0,23 segundos, y se sitúa por debajo de los 0,40 segundos.
El tamaño HTML de la página es adecuado: 139 kB.

Cabecera HTTP

NombreValor
content-typetext/html; charset=UTF-8
cache-controlmax-age=60, public, s-maxage=86400
x-drupal-dynamic-cacheMISS
content-languageen
x-content-type-optionsnosniff
x-frame-optionsSAMEORIGIN
expiresSun, 19 Nov 1978 05:00:00 GMT
x-generatorDrupal 10 (https://www.drupal.org)
last-modifiedSun, 27 Oct 2024 07:41:02 GMT
etag"1730014862-gzip"
x-request-idv-d0b13a32-9436-11ef-a844-d70cda4d8595
x-ah-environmentprod
x-cache-hits17
x-age140
accept-rangesbytes
x-akamai-transformed9 18904 0 pmb=mRUM,1
content-encodinggzip
dateSun, 27 Oct 2024 14:22:30 GMT
content-length20952
varyAccept-Encoding
server-timingcdn-cache; desc=REVALIDATE
strict-transport-securitymax-age=15768000
statuscode200
http_versionHTTP/2

Factores externos

Wikipedia enlaza esta página en sus fuentes.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 1.176 dominios de referencia.
Esta página recibe un total de 133.334 backlinks.
Esta página recibe backlinks de 971 direcciones IP distintas.

Backlinks desde Wikipedia

Descubre más links en la función de búsqueda de Wikipedia

Robots.txt

Sitemap: https://www.iconplc.com/sitemap.xml

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files
Disallow: /README.txt
Disallow: /web.config
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips/
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register/
Disallow: /user/password/
Disallow: /user/login/
Disallow: /user/logout/
# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips/
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password/
Disallow: /index.php/user/register/
Disallow: /index.php/user/login/
Disallow: /index.php/user/logout/
# Custom Paths
Disallow: /clients/*

Páginas similares

Snippet (vista previa de los resultados de búsqueda)

www.iconplc.com
ICON plc | Clinical Research Organisation (CRO) for Drug Development
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
Clinical83%Check
ICON83%Check
Clinical Development79%Check
Development76%Check
ICON plc75%Check
Clinical Research74%Check
Clinical Trials66%Check
Drug Development66%Check
Clinical solutions66%Check
Early Clinical65%Check
Mostrar más palabras clave

¡Analiza ya gratis hasta 1.000 páginas de iconplc.com!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Aviso legal | Privacidad y Cookies

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses